+Advanced Search
Home > Archive>Volume 31, Issue 11, 2021 >127-131. DOI:10. 3969 / j.issn.1671-7856. 2021. 11. 019
PDF HTML XML Export Cite reminder
MicroRNA in irritable bowel syndrome: a review on present strategies
CSTR:
[cstr]
Author:
Affiliation:

1.Chengdu University of Traditional Chinese Medicine, College of Acupuncture and Massage, Chengdu 610075, China. 2. Chengdu University of Traditional Chinese Medicine, College of Basic Medicine,Chengdu 610075

Clc Number:

R-33

  • Article
    • | |
  • Metrics
    • |
  • Reference
    • |
  • Related
    • |
  • Cited by
    • | |
  • Comments
    Abstract:

    Irritable bowel syndrome ( IBS) is a common functional gastrointestinal disorder. The lack of early diagnostic method and effective pharmacotherapy of IBS is predominantly attributed to the current limited understanding of its pathogenesis. MicroRNA (miRNA) is a class of small noncoding RNA of approximately 22 nt in length, which regulate gene expression by post-transcriptional repression or degradation of mRNAs, most often leading to gene silencing. Studies have revealed various differentially expressed miRNAs in colon tissue and peripheral blood of IBS patients. MiRNA has varying degrees of influence on the intestinal flora of IBS patients, the intestinal mucosal barrier, and low grade intestinal inflammation. This review focuses on miRNAs in IBS to find evidence of miRNA involvement in IBS pathogenesis and verify the diagnostic and therapeutic value of miRNA in IBS.

    Reference
    Related
    Cited by
Get Citation

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 19,2021
  • Online: December 17,2021
Article QR Code
You are the first Visitors
® 2025 All Rights Reserved
Address：5 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China Postcode： Phone：86-10-67779337 E-mail:bjb@cnilas.org
Supported by:Beijing E-Tiller Technology Development Co., Ltd.